Garside P, Bunce C, Tomlinson R C, Nichols B L, Mowat A M
Department of Immunology, University of Glasgow, Western Infirmary.
Cytokine. 1993 Jan;5(1):24-30. doi: 10.1016/1043-4666(93)90020-6.
Tumour necrosis factor (TNF)-alpha has been implicated in the pathogenesis of experimental and clinical enteropathy, but its exact role is unknown. We show here that a single dose of TNF-alpha causes significant small intestinal pathology in normal adult mice, which develops within 15 minutes, persists for up to 48 hours and is enhanced by interferon-gamma (IFN-gamma). The enteropathy consists of villus atrophy and crypt hyperplasia and is therefore similar to that found in immunologically mediated enteropathies such as graft-versus-host reaction (GvHR). TNF-alpha is also cytotoxic to an intestinal crypt cell line in vitro. Thus, a direct action of TNF-alpha on crypt cells may be involved in its enteropathic effects in vivo. Together, these findings indicate that TNF-alpha alone, or in concert with other cytokines, may be an important effector molecule in immunologically mediated intestinal pathology and may ultimately provide a target for specific immunotherapy for clinical enteropathies.
肿瘤坏死因子(TNF)-α已被认为与实验性和临床肠病的发病机制有关,但其确切作用尚不清楚。我们在此表明,单剂量的TNF-α会在正常成年小鼠中引起显著的小肠病理变化,这种变化在15分钟内出现,持续长达48小时,并被干扰素-γ(IFN-γ)增强。这种肠病表现为绒毛萎缩和隐窝增生,因此与免疫介导的肠病如移植物抗宿主反应(GvHR)中发现的情况相似。TNF-α在体外对一种小肠隐窝细胞系也具有细胞毒性。因此,TNF-α对隐窝细胞的直接作用可能与其在体内的肠病效应有关。总之,这些发现表明,单独的TNF-α或与其他细胞因子协同作用,可能是免疫介导的肠道病理中的一个重要效应分子,并最终可能为临床肠病的特异性免疫治疗提供一个靶点。